These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21827725)

  • 21. Increased plasma endothelin levels in patients with insulin-dependent diabetes mellitus and end-stage vascular complications.
    Kirilov G; Dakovska L; Borisova AM; Krivoshiev S; Nentchev N
    Horm Metab Res; 1994 Feb; 26(2):119-20. PubMed ID: 8200615
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of renal microvascular complications in diabetes mellitus.
    Veldman BA; Vervoort G
    Neth J Med; 2002 Nov; 60(10):390-6. PubMed ID: 12607589
    [No Abstract]   [Full Text] [Related]  

  • 24. NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus.
    Huelsmann M; Neuhold S; Strunk G; Moertl D; Berger R; Prager R; Abrahamian H; Riedl M; Pacher R; Luger A; Clodi M
    Eur Heart J; 2008 Sep; 29(18):2259-64. PubMed ID: 18650200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microvascular and macrovascular complications associated with diabetes in children and adolescents.
    Donaghue KC; Chiarelli F; Trotta D; Allgrove J; Dahl-Jorgensen K
    Pediatr Diabetes; 2009 Sep; 10 Suppl 12():195-203. PubMed ID: 19754630
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetic nephropathy: has the time come to move beyond plasma creatinine?
    Osman MM; Ahmed MH
    Ren Fail; 2006; 28(6):525-6. PubMed ID: 16928625
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fibrinogen and diabetic microangiopathy].
    Mojto V
    Vnitr Lek; 1997 Feb; 43(2):81-6. PubMed ID: 9245073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study.
    Brunkhorst R; Lufft V; Dannenberg B; Kliem V; Tusch G; Pichlmayr R
    Transplantation; 2003 Jul; 76(1):115-9. PubMed ID: 12865796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic complications: current challenges and opportunities.
    Nickerson HD; Dutta S
    J Cardiovasc Transl Res; 2012 Aug; 5(4):375-9. PubMed ID: 22752737
    [No Abstract]   [Full Text] [Related]  

  • 30. To: Looker HC, Fagot-Campagna A, Gunter EW et al. (2003) Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia 46:766-772.
    Shukla N; Angelini GD; Jeremy JY
    Diabetologia; 2004 Jan; 47(1):140-1. PubMed ID: 14628110
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lipoproteins and diabetic nephropathy].
    Bertsch T; Aufenanger J
    Med Klin (Munich); 1998 Jan; 93(1):57-8. PubMed ID: 9505083
    [No Abstract]   [Full Text] [Related]  

  • 32. High mortality persists for adults with type 1 diabetes.
    BMJ; 2012 Oct; 345():e6730. PubMed ID: 23054047
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinico-diagnostic significance of fibronectin determination in diabetes mellitus in children].
    Popova VA; Ostashevskaia MI; Podgorodnichenko VK
    Pediatriia; 1990; (6):9-12. PubMed ID: 2395632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular disease risk in young people with type 1 diabetes.
    Snell-Bergeon JK; Nadeau K
    J Cardiovasc Transl Res; 2012 Aug; 5(4):446-62. PubMed ID: 22528676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal analysis of blood pressure, lipid, and glycemic control in diabetic patients with nephropathy attending a hospital outpatient clinic and their relationship to renal function, mortality, and cardiovascular morbidity.
    Wahid ST; Baines LA; Savopoulos L; Connolly VM; Kelly WF; Bilous RW
    Diabetes Care; 2001 Apr; 24(4):789-90. PubMed ID: 11315853
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vascular risk in diabetes].
    Lubetzki J
    Sem Hop Ther; 1973 Sep; 49 Spec No():91-3. PubMed ID: 4804048
    [No Abstract]   [Full Text] [Related]  

  • 37. Pregnancy-associated plasma protein A and mortality in haemodialysis.
    Nilsson E; Rudholm T; Stenvinkel P; Ärnlöv J
    Eur J Clin Invest; 2018 Aug; 48(8):e12959. PubMed ID: 29802620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers of vascular complications in type 2 diabetes.
    Tremblay J; Hamet P
    Metabolism; 2015 Mar; 64(3 Suppl 1):S28-32. PubMed ID: 25468145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular disease risk in type 1 diabetes.
    Anagnostis P; Godsland IF
    Lancet Diabetes Endocrinol; 2015 May; 3(5):316-7. PubMed ID: 25943752
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular disease risk in type 1 diabetes - Authors' reply.
    Huxley RR; Peters SA; Mishra GD; Woodward M
    Lancet Diabetes Endocrinol; 2015 May; 3(5):317. PubMed ID: 25943754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.